» Articles » PMID: 29422650

Evaluating the Potential of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells to Form Microvascular Networks in 3D Cultures

Overview
Journal Sci Rep
Specialty Science
Date 2018 Feb 10
PMID 29422650
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

A major translational challenge in the fields of therapeutic angiogenesis and regenerative medicine is the need to create functional microvasculature. The purpose of this study was to assess whether a potentially autologous endothelial cell (EC) source derived from human induced pluripotent stem cells (iPSC-ECs) can form the same robust, stable microvasculature as previously documented for other sources of ECs. We utilized a well-established in vitro assay, in which endothelial cell-coated (iPSC-EC or HUVEC) beads were co-embedded with fibroblasts in a 3D fibrin matrix to assess their ability to form stable microvessels. iPSC-ECs exhibited a five-fold reduction in capillary network formation compared to HUVECs. Increasing matrix density reduced sprouting, although this effect was attenuated by distributing the NHLFs throughout the matrix. Inhibition of both MMP- and plasmin-mediated fibrinolysis was required to completely block sprouting of both HUVECs and iPSC-ECs. Further analysis revealed MMP-9 expression and activity were significantly lower in iPSC-EC/NHLF co-cultures than in HUVEC/NHLF co-cultures at later time points, which may account for the observed deficiencies in angiogenic sprouting of the iPSC-ECs. Collectively, these findings suggest fundamental differences in EC phenotypes must be better understood to enable the promise and potential of iPSC-ECs for clinical translation to be realized.

Citing Articles

Vascularised organoids: Recent advances and applications in cancer research.

Zhou R, Brislinger D, Fuchs J, Lyons A, Langthaler S, Hauser C Clin Transl Med. 2025; 15(3):e70258.

PMID: 40045486 PMC: 11882480. DOI: 10.1002/ctm2.70258.


Microfluidic model of the alternative vasculature in neuroblastoma.

Villasante A, Lopez-Martinez M, Quinonero G, Garcia-Lizarribar A, Peng X, Samitier J In Vitro Model. 2025; 3(1):49-63.

PMID: 39872066 PMC: 11756480. DOI: 10.1007/s44164-023-00064-x.


NOS3 regulates angiogenic potential of human induced pluripotent stem cell-derived endothelial cells.

Kong A, Idris Z, Urrutia-Cabrera D, Lees J, Phang R, Mitchell G Biochem Biophys Rep. 2024; 40:101876.

PMID: 39634339 PMC: 11616527. DOI: 10.1016/j.bbrep.2024.101876.


Studying the Pulmonary Endothelium in Health and Disease: An Official American Thoracic Society Workshop Report.

Hough R, Alvira C, Bastarache J, Erzurum S, Kuebler W, Schmidt E Am J Respir Cell Mol Biol. 2024; 71(4):388-406.

PMID: 39189891 PMC: 11450313. DOI: 10.1165/rcmb.2024-0330ST.


Building a human lung from pluripotent stem cells to model respiratory viral infections.

Turner D, Amoozadeh S, Baric H, Stanley E, Werder R Respir Res. 2024; 25(1):277.

PMID: 39010108 PMC: 11251358. DOI: 10.1186/s12931-024-02912-0.


References
1.
Sternlicht M, Werb Z . How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17:463-516. PMC: 2792593. DOI: 10.1146/annurev.cellbio.17.1.463. View

2.
Wong W, Sayed N, Cooke J . Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine. Methodist Debakey Cardiovasc J. 2013; 9(4):206-9. PMC: 3846074. DOI: 10.14797/mdcj-9-4-206. View

3.
Toth M, Chvyrkova I, Bernardo M, Hernandez-Barrantes S, Fridman R . Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun. 2003; 308(2):386-95. DOI: 10.1016/s0006-291x(03)01405-0. View

4.
Addis R, Campesi I, Fois M, Capobianco G, Dessole S, Fenu G . Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells. Biol Sex Differ. 2014; 5(1):18. PMC: 4273493. DOI: 10.1186/s13293-014-0018-2. View

5.
Ghajar C, George S, Putnam A . Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr. 2008; 18(3):251-78. PMC: 2905732. DOI: 10.1615/critreveukargeneexpr.v18.i3.30. View